111 - Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5)
- Resource Type
- Abstract
- Source
- In
Canadian Journal of Diabetes October 2016 40(5) Supplement:S41-S42 - Subject
- Language
- ISSN
- 1499-2671